Nano-Bio Innovation SeminarWhen: Wednesday, April 03, 2013 at 4:40 pm
Where: SH 335
Speaker: Paul Glavin, PhD
Organization: Life Sciences Interface Group, Tyndall National Institute, Cork, Ireland
Sponsor: IGERT Nanomedicine Science & Technology
Dr Paul GALVIN was awarded his PhD in 1995 and joined the Tyndall National Institute (then
NMRC), in 2000 where he now leads the Life Sciences Interface Group. Research within the
Life Sciences Interface Group is focussed on exploiting the extensive design, fabrication and
characterisation tools available in Tyndall, for applications related to health and environment.
Within his role as leader of the Life Sciences Interface Group in Tyndall, he has facilitated the
development of new collaborative research programmes through engagement with senior
representatives of leading medical device companies. Dr Galvin initiated, wrote and
coordinated a number of large international multidisciplinary research projects such as CFCHIP
(EC FP5 programme ‐ €2.3 million) and SNiP2CHIP (EC FP6 programme ‐ €3.2 million). He
was one of the founding members of Nano2Life, the European Network of Excellence (NoE) on
Nanobiotechnology. In June 2011, he chaired the Organising Committee for the
NanoBioEurope 2011 conference in Cork (Ireland), attended by delegates from 20 countries.
To date, his research has been supported by EU FP5, 6 & 7 programmes in Health, NMP & ICT,
as well as having projects funded by SFI, Enterprise Ireland and the Higher Education
Authority, with awarded grants for his research in excess of €4.0 million. He has served as an
expert reviewer for several funding agencies including EC FP5, FP6 and FP7 programmes. He
has been a co‐inventor on three filed patent applications, has over 60 international
publications and has presented his research at international conferences around the world
(including many invited papers and presentations) across a diversity of scientific disciplines.